TCM
CRL icon

Tygh Capital Management’s Charles River Laboratories CRL Stock Holding History

Tygh Capital Management’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-16,374
Closed -$6.76M – 90
2021
Q3 		$6.76M Sell
16,374
-3,427
-17% -$1.42M 0.91% 56
2021
Q2 		$7.33M Sell
19,801
-216
-1% -$72.1K 1% 50
2021
Q1 		$5.8M Sell
20,017
-3,316
-14% -$922K 0.82% 55
2020
Q4 		$5.83M Sell
23,333
-11,577
-33% -$2.76M 0.91% 53
2020
Q3 		$7.91M Sell
34,910
-28,248
-45% -$5.86M 1.5% 24
2020
Q2 		$11M Sell
63,158
-3,953
-6% -$631K 2.3% 8
2020
Q1 		$8.47M Buy
67,111
+290
+0.4% +$43.5K 1.9% 18
2019
Q4 		$10.2M Sell
66,821
-440
-0.7% -$60.9K 1.69% 20
2019
Q3 		$8.9M Buy
67,261
+36,371
+118% +$4.88M 1.58% 24
2019
Q2 		$4.38M Sell
30,890
-11,501
-27% -$1.56M 0.74% 66
2019
Q1 		$6.16M Sell
42,391
-25,201
-37% -$3.31M 1.08% 44
2018
Q4 		$7.65M Buy
67,592
+15,532
+30% +$1.94M 1.6% 21
2018
Q3 		$7M Buy
+52,060
New +$6.43M 1.15% 37
2018
Q1 		– Sell
-64,356
Closed -$7.04M – 95
2017
Q4 		$7.04M Buy
64,356
+28,249
+78% +$3.07M 1.33% 20
2017
Q3 		$3.9M Sell
36,107
-14,460
-29% -$1.49M 0.78% 66
2017
Q2 		$5.12M Sell
50,567
-11,220
-18% -$1.03M 1.16% 38
2017
Q1 		$5.56M Buy
61,787
+30,885
+100% +$2.62M 1.3% 31
2016
Q4 		$2.35M Buy
+30,902
New +$2.35M 0.59% 77

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Tygh Capital Management's CRL Position: Q4 2021 in Review

Tygh Capital Management sold out of Charles River Laboratories (CRL) in Q4 2021, closing a stake of 16,374 shares — an estimated $6.76M sold.

Tygh Capital Management first reported a position in CRL in Q4 2016 and held it in 18 quarters. The position peaked at $11M in Q2 2020. 707 funds tracked by Wall St. Rank hold CRL as of Q4 2021.

  • Tygh Capital Management reported no remaining Charles River Laboratories position as of Q4 2021 after selling out during the quarter.
  • Tygh Capital Management sold 16,374 Charles River Laboratories shares in Q4 2021, an estimated $6.76M.
  • Tygh Capital Management first reported a position in Charles River Laboratories in Q4 2016 and held it in 18 quarters.
  • Tygh Capital Management's Charles River Laboratories position peaked at $11M in Q2 2020.
  • 707 funds tracked by Wall St. Rank held Charles River Laboratories as of Q4 2021.

Based on Tygh Capital Management's 13F filing for Q4 2021, filed 10 Feb 2022.